IL174369A0 - Methods for treating bladder dysfunction - Google Patents

Methods for treating bladder dysfunction

Info

Publication number
IL174369A0
IL174369A0 IL174369A IL17436906A IL174369A0 IL 174369 A0 IL174369 A0 IL 174369A0 IL 174369 A IL174369 A IL 174369A IL 17436906 A IL17436906 A IL 17436906A IL 174369 A0 IL174369 A0 IL 174369A0
Authority
IL
Israel
Prior art keywords
methods
bladder dysfunction
treating bladder
dysfunction
treating
Prior art date
Application number
IL174369A
Other languages
English (en)
Original Assignee
Bioxell Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0322395A external-priority patent/GB0322395D0/en
Priority claimed from GB0325598A external-priority patent/GB2407499B/en
Priority claimed from GB0404571A external-priority patent/GB0404571D0/en
Priority claimed from GB0404567A external-priority patent/GB0404567D0/en
Priority claimed from GB0416876A external-priority patent/GB0416876D0/en
Application filed by Bioxell Spa filed Critical Bioxell Spa
Publication of IL174369A0 publication Critical patent/IL174369A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL174369A 2003-09-24 2006-03-16 Methods for treating bladder dysfunction IL174369A0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0322395A GB0322395D0 (en) 2003-09-24 2003-09-24 Methods for treating bladder dysfunction and related compounds and compositions
GB0325598A GB2407499B (en) 2003-11-03 2003-11-03 Vitamin D3 analogue for use in the treatment of BPH
GB0404571A GB0404571D0 (en) 2004-03-01 2004-03-01 Methods for treating interstitial cystitis and related compounds and compositions
GB0404567A GB0404567D0 (en) 2004-03-01 2004-03-01 Methods for treating bladder dysfunction and related compounds and compositions
GB0416876A GB0416876D0 (en) 2004-07-29 2004-07-29 Compound and use in treatment
PCT/US2004/031532 WO2005030223A1 (en) 2003-09-24 2004-09-24 Methods for treating bladder dysfunction

Publications (1)

Publication Number Publication Date
IL174369A0 true IL174369A0 (en) 2006-08-01

Family

ID=34397209

Family Applications (1)

Application Number Title Priority Date Filing Date
IL174369A IL174369A0 (en) 2003-09-24 2006-03-16 Methods for treating bladder dysfunction

Country Status (8)

Country Link
US (1) US20070054887A1 (enExample)
EP (1) EP1663250A4 (enExample)
JP (1) JP2007506780A (enExample)
AU (1) AU2004275845A1 (enExample)
BR (1) BRPI0414701A (enExample)
CA (1) CA2540325A1 (enExample)
IL (1) IL174369A0 (enExample)
WO (1) WO2005030223A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005082375A2 (en) * 2004-03-01 2005-09-09 Bioxell Spa Treatment of interstitial cystitis with vitamin d compounds
WO2006036813A2 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
WO2006051106A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
CN101790311B (zh) * 2007-08-23 2014-04-23 泰拉科斯有限公司 苄基苯衍生物及使用方法
US7737028B2 (en) * 2007-09-28 2010-06-15 Applied Materials, Inc. Selective ruthenium deposition on copper materials
US8222236B2 (en) * 2008-07-10 2012-07-17 Wisconsin Alumni Research Foundation 2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs
WO2014063105A1 (en) * 2012-10-19 2014-04-24 Celus Pharmaceuticals, Inc. Vitamin d analogues for the treatment of a neurological disorder
JP6898918B2 (ja) * 2016-03-24 2021-07-07 ダイワボウホールディングス株式会社 模様付き不織布およびその製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
TW403735B (en) * 1995-11-22 2000-09-01 Hoffmann La Roche 25-hydroxy-16-ene-26, 27-bishomo-cholecalciferol
US5747479A (en) * 1996-01-03 1998-05-05 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
US5939408A (en) * 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
US5811414A (en) * 1997-05-16 1998-09-22 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
EP1622455A4 (en) * 2003-04-30 2009-12-16 Bioxell Spa GEMINI VITAMIN D3 COMPOUNDS AND METHODS OF USING THE SAME
WO2004098507A2 (en) * 2003-04-30 2004-11-18 Bioxell S.P.A. 1,3 aclyated 24-keto-vitamin d3 compounds and methods of use thereof

Also Published As

Publication number Publication date
CA2540325A1 (en) 2005-04-07
AU2004275845A1 (en) 2005-04-07
EP1663250A1 (en) 2006-06-07
JP2007506780A (ja) 2007-03-22
EP1663250A4 (en) 2006-12-20
WO2005030223A1 (en) 2005-04-07
US20070054887A1 (en) 2007-03-08
BRPI0414701A (pt) 2006-11-14

Similar Documents

Publication Publication Date Title
GB2428065B (en) Desalination method
ZA200508427B (en) Methods for treating interleuking-6 related diseases
EP1715799A4 (en) METHOD FOR TREATING GLAUCOMA
IL183985A0 (en) Methods for treating autoimmune disorders
IL164352A0 (en) Methods for treating tweak-related conditions
IL175818A0 (en) Method for treating adamts-5- associated disease
ZA200705059B (en) Cancer treatment method
EP1755394A4 (en) METHOD OF TREATING CANCER
EP1725237A4 (en) ANTI-ALCOHOLIC TREATMENT
IL174369A0 (en) Methods for treating bladder dysfunction
IL179323A0 (en) Cancer treatment method
ZA200607115B (en) Permanent treatment method
EP1742629A4 (en) METHOD FOR TREATING ALCOHOLISM
EP1809276A4 (en) PROCESSING PROCESS
IL179359A0 (en) Cancer treatment method
EP1802617A4 (en) CANCER TREATMENT METHOD
GB0307544D0 (en) Treatment method
HK1091411A (en) Methods for treating bladder dysfunction
GB0322395D0 (en) Methods for treating bladder dysfunction and related compounds and compositions
GB0302691D0 (en) Treatment method
GB0312122D0 (en) Therapeutic method
GB2399341B (en) Water treatment method
GB0404567D0 (en) Methods for treating bladder dysfunction and related compounds and compositions
GB0325838D0 (en) Wastewater treatment
GB0316965D0 (en) Method for treating wastewater